Evidence map›Paper›PMID 15467822›Full record

ArticleThe Journal of clinical investigation2004

Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus.

Kristina I Rother, David M Harlan

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Current status of pancreatic islet xenotransplantation.Clinical transplantation and research · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Understanding the Structural Arrangement of Islets in Chronic Pancreatitis.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2024
    Article
  15. Article
  16. Review
  17. Review
  18. Islet allografts expressing a PD-L1 and IDO fusion protein evade immune rejection and reverse preexisting diabetes in immunocompetent mice without systemic immunosuppression.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
  19. Review
  20. Review

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kristina I RotherIslet and Autoimmunity Branch, National Institutes of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland 20892, USA.
David M Harlan

Funding

AC2993 effects on pacreatic Islet functionZ01DK055104 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI HARLAN, DAVID · 2005 to 2008
$609k
Immunological Mechanisms Underlying T1dm PathogenesisZ01DK062002 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI HARLAN, DAVID · 2000 to 2008
$566k
Secondary Prevention Trials For Type 1 Diabetes MellitusZ01DK062001 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI HARLAN, DAVID · 2000 to 2008
$466k
Islet Cell Transplantation For T1dm: Clinical Studies AnZ01DK062000 · NIDDK · DIABETES, DIGESTIVE, KIDNEY DISEASES · PI HARLAN, DAVID · 2000 to 2006
–
Intramural NIH HHS Z99 DK999999
6 · The paper itself

Abstract

Islet transplantation represents a most impressive recent advance in the search for a type 1 diabetes mellitus cure. While several hundred patients have achieved at least temporary insulin independence after receiving the islet "mini-organs" (containing insulin-producing beta cells), very few patients remain insulin independent beyond 4 years after transplantation. In this review, we describe historic as well as technical details about the procedure and provide insight into clinical and basic research efforts to overcome existing hurdles for this promising therapy.

Indexed as

Islets of Langerhans TransplantationAge FactorsBlood GlucoseDiabetes Mellitus, Type 1Graft SurvivalHumansImmunosuppressive AgentsInsulinTreatment OutcomeBlood GlucoseImmunosuppressive AgentsInsulin

Identifiers

PMID15467822
PMCPMC518676

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.